Department of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan.
Drug Resist Updat. 2012 Jun;15(3):133-48. doi: 10.1016/j.drup.2012.05.001. Epub 2012 Jun 4.
Exogenously acquired 16S rRNA methyltransferase (16S-RMTase) genes responsible for a very high level of resistance against various aminoglycosides have been widely distributed among Enterobacteriaceae and glucose-nonfermentative microbes recovered from human and animal. The 16S-RMTases are classified into two subgroups, N7-G1405 16S-RMTases and N1-A1408 16S-RMTases, based on the mode of modification of 16S rRNA. Both MTases add the methyl group of S-adenosyl-L-methionine (SAM) to the specific nucleotides at the A-site of 16S rRNA, which interferes with aminoglycoside binding to the target. The genetic determinants responsible for 16S-RMTase production are often mediated by mobile genetic elements like transposons and further embedded into transferable plasmids or chromosome. This genetic apparatus may thus contribute to the rapid worldwide dissemination of the resistance mechanism among pathogenic microbes. More worrisome is the fact that 16S-RMTase genes are frequently associated with other antimicrobial resistance mechanisms such as NDM-1 metallo-β-lactamase and CTX-M-type ESBLs, and some highly pathogenic microbes including Salmonella spp. have already acquired these genes. Thus far, 16S-RMTases have been reported from at least 30 countries or regions. The worldwide dissemination of 16S-RMTases is becoming a serious global concern and this implies the necessity to continue investigations on the trend of 16S-RMTases to restrict their further worldwide dissemination.
外源性获得的 16S rRNA 甲基转移酶(16S-RMTase)基因可导致对各种氨基糖苷类药物的高度耐药性,广泛分布于肠杆菌科和从人和动物中分离的非葡萄糖发酵微生物中。根据 16S rRNA 修饰方式,16S-RMTases 可分为 N7-G1405 16S-RMTases 和 N1-A1408 16S-RMTases 两个亚群。两种 MTase 将 S-腺苷-L-甲硫氨酸(SAM)的甲基加到 16S rRNA A 位的特定核苷酸上,从而干扰氨基糖苷类药物与靶标结合。产生 16S-RMTase 的遗传决定因素通常由转座子等移动遗传元件介导,并进一步嵌入可转移质粒或染色体中。因此,这种遗传装置可能有助于耐药机制在病原微生物中迅速在全球范围内传播。更令人担忧的是,16S-RMTase 基因经常与其他抗菌药物耐药机制如 NDM-1 金属β-内酰胺酶和 CTX-M 型 ESBLs 相关,包括沙门氏菌属在内的一些高致病性微生物已经获得了这些基因。迄今为止,至少有 30 个国家或地区报告了 16S-RMTases。16S-RMTases 在全球范围内的传播已成为一个严重的全球关注问题,这意味着有必要继续调查 16S-RMTases 的流行趋势,以限制其在全球范围内的进一步传播。